Literature DB >> 627935

Monomethylformamide levels in human urine after repetitive exposure to dimethylformamide vapor.

N D Krivanek, M McLaughlin, W E Fayweather.   

Abstract

Eight healthy male subjects were exposed to DMF vapor at a concentration of 8.79 +/- 0.33 ppm for six hours daily for five consecutive days. All urine voided by the subjects was collected from the beginning of the first exposure to 24 hours past the end of the last exposure and each sample was analyzed for monomethylformamide (MMF). MMF was rapidly eliminated from the body with urine values peaking within a few hours following the end of each exposure period. Very little was found in the 24-hour postexposure sample and none was found in a 48-hour postexposure sample. There was no increased excretion of MMF in the urine following repetitive exposure. The mean for the seven-hour (end of exposure) sample was 4.74 microgram/ml or 736.8 microgram. Lower and upper one-sided 95% tolerance limits for 95% of the population were 1.2 microgram/ml (367 microgram) and 13.9 microgram/ml (1625 microgram). The coefficient of variation (CV) for microgram MMF/ml was approximately 25 times more variable than the CV for total microgram.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 627935     DOI: 10.1097/00043764-197803000-00005

Source DB:  PubMed          Journal:  J Occup Med        ISSN: 0096-1736


  10 in total

1.  Occupational dimethylformamide exposure. 2. Monomethylformamide excretion in urine after occupational dimethylformamide exposure.

Authors:  T Kawai; T Yasugi; K Mizunuma; T Watanabe; S X Cai; M Y Huang; L Q Xi; J B Qu; B Z Yao; M Ikeda
Journal:  Int Arch Occup Environ Health       Date:  1992       Impact factor: 3.015

2.  External and internal monitoring in workers exposed to N,N-dimethylformamide.

Authors:  R Wrbitzky; J Angerer; G Lehnert
Journal:  Int Arch Occup Environ Health       Date:  1996       Impact factor: 3.015

3.  Biological surveillance of workers exposed to dimethylformamide and the influence of skin protection on its percutaneous absorption.

Authors:  R R Lauwerys; A Kivits; M Lhoir; P Rigolet; D Houbeau; J P Buchet; H A Roels
Journal:  Int Arch Occup Environ Health       Date:  1980       Impact factor: 3.015

4.  Relation of exposure to dimethylformamide vapor and the metabolite, methylformamide, in urine of workers.

Authors:  J Yonemoto; S Suzuki
Journal:  Int Arch Occup Environ Health       Date:  1980       Impact factor: 3.015

5.  In vivo metabolism of dimethylformamide and relationship to toxicity in the male rat.

Authors:  V Scailteur; R Lauwerys
Journal:  Arch Toxicol       Date:  1984-12       Impact factor: 5.153

6.  Dimethylformamide and alcohol intolerance.

Authors:  W H Lyle; T W Spence; W M McKinneley; K Duckers
Journal:  Br J Ind Med       Date:  1979-02

7.  Absorption, metabolism and elimination of N,N-dimethylformamide in humans.

Authors:  J Mráz; H Nohová
Journal:  Int Arch Occup Environ Health       Date:  1992       Impact factor: 3.015

8.  Dose-dependent effects of peroral dimethylformamide administration on rat brain.

Authors:  H Savolainen
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

9.  Biological monitoring of workers exposed to N, N-dimethylfomamide. I. Methods of analysis.

Authors:  A C Lareo; A Perico; P Bavazzano; C Soave; L Perbellini
Journal:  Int Arch Occup Environ Health       Date:  1995       Impact factor: 3.015

10.  Biological monitoring of workers exposed to N-N-dimethylformamide. II. Dimethylformamide and its metabolites in urine of exposed workers.

Authors:  A C Lareo; L Perbellini
Journal:  Int Arch Occup Environ Health       Date:  1995       Impact factor: 3.015

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.